Our Company
Who We Are
Umoja’s world-class team of scientists, researchers, and drug development experts are united by our shared goal of unlocking the true potential of CAR T cell therapies. Our deep experience, meticulous attention to detail, and innovative spirit drive us in our mission to extend the benefits of immunotherapy to every patient bearing the burden of cancer.
Leadership
SVP, Clinical Operations & Development
SVP, Regulatory Affairs
Head of Investor Relations
Board of Directors
Chairman of the Board
Co-founder & Chief Executive Officer
MPM Capital
DCVC Bio
Qiming Venture Partners USA
Purdue University, Co-founder, Umoja Biopharma, Scientific Advisory Board Co-chair
Advisory Board
Purdue University, Co-founder, Umoja Biopharma, Scientific Advisory Board Co-chair
Seattle Children's Hospital, Co-founder, Umoja Biopharma, Scientific Advisory Board Co-chair
Fred Hutch Endowed Chair for Cell and Gene Therapy
Ben Towne Center for Childhood Cancer
Henry Pitot Professor of Pathology & Laboratory Medicine, University of Wisconsin, Madison
Current Investors
Together, we are advancing the future of immunotherapy to change the lives of every patient bearing the burden of cancer. Learn more about our team of experts.